5 Best Small Cap Pharma Stocks to Buy

4. Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)

Number of Hedge Fund Investors in Q1 2023: 22

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) is an American firm headquartered in Waltham, Massachusetts. It develops crucial medicines that help people suffering from deadly cancers and tumors. Analysts have penned in a nice $7 share upside to the stock.

Insider Monkey scoured through 943 hedge funds for their Q1 2023 shareholdings and discovered that 22 had invested in the firm. Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)’s largest investor in our database is Jeremy Green’s Redmile Group through a stake worth $86 million.

Follow Deciphera Pharmaceuticals Inc. (NASDAQ:NA)